Φορτώνει......
Successful treatment of congestive heart failure with concomitant administration of tolvaptan to enhance the effects of furosemide
Tolvaptan (TLV), which is an antagonist to the vasopressin V2 receptor, was approved by Japanese authorities for the treatment of “volume overload in heart failure when adequate response is not obtained with other diuretics (e.g. loop diuretics)”. An 82-year-old female Japanese patient was admitted...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Cardiol Cases |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Japanese College of Cardiology
2013
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6277594/ https://ncbi.nlm.nih.gov/pubmed/30546768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jccase.2013.07.005 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|